Patents by Inventor Ioana Combaluzier

Ioana Combaluzier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HUMAN ISLET AMYLOID POLYPEPTIDE (HIAPP) SPECIFIC ANTIBODIES AND USES THEREOF
    Publication number: 20210107972
    Abstract: Provided are novel human islet amyloid polypeptide, also known as amylin and IAPP and proIAPP respectively, specific antibodies as well as fragments, derivatives and variants thereof as well as methods related thereto. Assays, kits, and solid supports related to antibodies specific for IAPP and/or proIAPP are also disclosed. The antibody, immunoglobulin chain(s), as well as binding fragments, derivatives and variants thereof can be used in pharmaceutical and diagnostic compositions for IAPP and/or proIAPP targeted immunotherapy and diagnostics, respectively.
    Type: Application
    Filed: December 7, 2020
    Publication date: April 15, 2021
    Inventors: Jan GRIMM, Fabrice HEITZ, Feng CHEN, Ioana COMBALUZIER
  • Human islet amyloid polypeptide (hIAPP) specific antibodies and uses thereof
    Patent number: 10882902
    Abstract: Provided are novel human islet amyloid polypeptide, also known as amylin and IAPP and proIAPP respectively, specific antibodies as well as fragments, derivatives and variants thereof as well as methods related thereto. Assays, kits, and solid supports related to antibodies specific for IAPP and/or proIAPP are also disclosed. The antibody, immunoglobulin chain(s), as well as binding fragments, derivatives and variants thereof can be used in pharmaceutical and diagnostic compositions for IAPP and/or proIAPP targeted immunotherapy and diagnostics, respectively.
    Type: Grant
    Filed: August 8, 2018
    Date of Patent: January 5, 2021
    Assignee: Neurimmune Holding AG
    Inventors: Jan Grimm, Fabrice Heitz, Feng Chen, Ioana Combaluzier
  • HUMAN ISLET AMYLOID POLYPEPTIDE (HIAPP) SPECIFIC ANTIBODIES AND USES THEREOF
    Publication number: 20180346558
    Abstract: Provided are novel human islet amyloid polypeptide, also known as amylin and IAPP and proIAPP respectively, specific antibodies as well as fragments, derivatives and variants thereof as well as methods related thereto. Assays, kits, and solid supports related to antibodies specific for IAPP and/or proIAPP are also disclosed. The antibody, immunoglobulin chain(s), as well as binding fragments, derivatives and variants thereof can be used in pharmaceutical and diagnostic compositions for IAPP and/or proIAPP targeted immunotherapy and diagnostics, respectively.
    Type: Application
    Filed: August 8, 2018
    Publication date: December 6, 2018
    Inventors: Jan GRIMM, Fabrice Heitz, Feng Chen, Ioana Combaluzier
  • Human islet amyloid polypeptide (HIAPP) specific antibodies and uses thereof
    Patent number: 10072074
    Abstract: Provided are novel human islet amyloid polypeptide, also known as amylin and IAPP and proIAPP respectively, specific antibodies as well as fragments, derivatives and variants thereof as well as methods related thereto. Assays, kits, and solid supports related to antibodies specific for IAPP and/or proIAPP are also disclosed. The antibody, immunoglobulin chain(s), as well as binding fragments, derivatives and variants thereof can be used in pharmaceutical and diagnostic compositions for IAPP and/or proIAPP targeted immunotherapy and diagnostics, respectively.
    Type: Grant
    Filed: September 7, 2016
    Date of Patent: September 11, 2018
    Assignee: Neurimmune Holding AG
    Inventors: Jan Grimm, Fabrice Heitz, Feng Chen, Ioana Combaluzier
  • HUMAN ISLET AMYLOID POLYPEPTIDE (HIAPP) SPECIFIC ANTIBODIES AND USES THEREOF
    Publication number: 20160376354
    Abstract: Provided are novel human islet amyloid polypeptide, also known as amylin and IAPP and proIAPP respectively, specific antibodies as well as fragments, derivatives and variants thereof as well as methods related thereto. Assays, kits, and solid supports related to antibodies specific for IAPP and/or proIAPP are also disclosed. The antibody, immunoglobulin chain(s), as well as binding fragments, derivatives and variants thereof can be used in pharmaceutical and diagnostic compositions for IAPP and/or proIAPP targeted immunotherapy and diagnostics, respectively.
    Type: Application
    Filed: September 7, 2016
    Publication date: December 29, 2016
    Inventors: Jan GRIMM, Fabrice Heitz, Feng Chen, Ioana Combaluzier
  • Human islet amyloid polypeptide (hIAPP) specific antibodies and uses thereof
    Patent number: 9475866
    Abstract: Provided are novel human islet amyloid polypeptide, also known as amylin and IAPP and proIAPP respectively, specific antibodies as well as fragments, derivatives and variants thereof as well as methods related thereto. Assays, kits, and solid supports related to antibodies specific for IAPP and/or proIAPP are also disclosed. The antibody, immunoglobulin chain(s), as well as binding fragments, derivatives and variants thereof can be used in pharmaceutical and diagnostic compositions for IAPP and/or proIAPP targeted immunotherapy and diagnostics, respectively.
    Type: Grant
    Filed: September 12, 2013
    Date of Patent: October 25, 2016
    Assignee: Neurimmune Holding AG
    Inventors: Jan Grimm, Fabrice Heitz, Feng Chen, Ioana Combaluzier
  • HUMAN ISLET AMYLOID POLYPEPTIDE (HIAPP) SPECIFIC ANTIBODIES AND USES THEREOF
    Publication number: 20150210759
    Abstract: Provided are novel human islet amyloid polypeptide, also known as amylin and IAPP and proIAPP respectively, specific antibodies as well as fragments, derivatives and variants thereof as well as methods related thereto. Assays, kits, and solid supports related to antibodies specific for IAPP and/or proIAPP are also disclosed. The antibody, immunoglobulin chain(s), as well as binding fragments, derivatives and variants thereof can be used in pharmaceutical and diagnostic compositions for IAPP and/or proIAPP targeted immunotherapy and diagnostics, respectively.
    Type: Application
    Filed: September 12, 2013
    Publication date: July 30, 2015
    Inventors: Jan Grimm, Fabrice Heitz, Feng Cheng, Ioana Combaluzier